Paxman AB (publ) (STO:PAX)
78.60
+2.00 (2.61%)
May 14, 2025, 11:00 AM CET
Paxman AB Company Description
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system.
Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.
Paxman AB (publ)
Country | Sweden |
Founded | 1996 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 105 |
CEO | Richard Paxman |
Contact Details
Address: Pirgatan 13 Karlshamn, 374 35 Sweden | |
Website | paxmanscalpcooling.com |
Stock Details
Ticker Symbol | PAX |
Exchange | Nasdaq Stockholm |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0009806284 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Liza Hirst | EA to Chief Executive Officer and Head of Human Resources |
Richard Paxman O.B.E. | Chief Executive Officer and Director |
Emelie Gustafsson | Chief Financial Officer |
Alexandra Sheldrake | Head of Quality and Operations |
Dr. Simon Taylor | Technical Manager |
Louise Aspey-Smith | Head of Brand and Marketing Manager |
Patrick Burke | Head of Research and Development |
Emma Thornhill | Finance Director |
Stuart Rowling | Head of UK Sales and Training |
Anna Parker | Head of International Sales |